NIH-funded research U01 cooperative agreement

Improving recovery from radiation damage in the intestines

Official title: Mitigation of gastrointestinal acute radiation syndrome by promoting clusterin-mediated intestinal regeneration

Funded at Duke University · NIH-11015450 · Data updated 2026-11-12

This study is looking at how a special protein called Clusterin can help the intestines heal after they've been hurt by radiation, which can happen in situations like nuclear accidents, and the goal is to find new ways to help people recover better from radiation-related injuries.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startDecember 2, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$515,326
NIH project number1U01AI186969-01
Project IDNIH-11015450 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to high levels of radiation, such as in nuclear accidents or warfare.

Less likely to help

Patients who have not been exposed to radiation or who have other unrelated gastrointestinal conditions may not benefit from this research.

What this research studies

This research focuses on understanding how the intestines can heal after being damaged by radiation, which can occur during nuclear accidents or warfare. The team is investigating a protein called Clusterin that plays a crucial role in the regeneration of intestinal cells after radiation exposure. By exploring the mechanisms behind this process, they aim to develop new treatments that could help patients recover from acute radiation syndrome more effectively. The research involves both laboratory studies and potential therapeutic applications to promote healing in the intestines.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery from radiation-induced intestinal damage.

How similar studies have gone: Previous research has shown promise in using similar biological pathways to promote healing in other contexts, suggesting potential for success in this novel approach.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Lee, Chang-Lung — Duke University
  • Study coordinator: Lee, Chang-Lung

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.